Stephen D. Shafran
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Mycobacterium research and diagnosis
Most-Cited Works
- → Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection(2015)1,110 cited
- → Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3(2007)490 cited
- → Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials(2017)236 cited
- → Uveitis and Pseudojaundice During a Regimen of Clarithromycin, Rifabutin, and Ethambutol(1994)130 cited
- → Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis(2019)123 cited
- → Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts(2020)105 cited
- → Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial(2023)69 cited
- → Management of chronic hepatitis C: Consensus guidelines(2007)45 cited
- → Topical Undecylenic Acid for Herpes Simplex Labialis: A Multicenter, Placebo‐Controlled Trial(1997)29 cited
- → Norfloxacin Is Inferior to Chloroquine for Falciparum Malaria in Northwestern Zambia: A Comparative Clinical Trial(1992)27 cited